Myxedema coma: four patients diagnosed at the Internal Medicine Department of the Dr. Negrin University Hospital in Spain
- PMID: 31762876
- PMCID: PMC6850735
- DOI: 10.11604/pamj.2019.34.7.19164
Myxedema coma: four patients diagnosed at the Internal Medicine Department of the Dr. Negrin University Hospital in Spain
Abstract
Myxedema coma is a rare complication of hypothyroidism. Clinical examination may reveal hypotension, bradycardia, and hypothermia. Laboratory tests may show hyponatremia, lipid disorders, and elevations of creatine kinase, liver, and cardiac enzymes. We describe four cases diagnosed in our hospital during the period 1999-2017. The patients were related to amiodarone treatment, noncompliance with hormone replacement therapy, or a new diagnosis of hypothyroidism. Intravenous hormone replacement therapy was effective in three of the cases and one died. The outcome of this disease may be fatal as seen in one of our cases.
Keywords: Myxedema coma; hormone replacement therapy; hypothyroidism.
© Noel Lorenzo Villalba et al.
Conflict of interest statement
The authors declare no competing interests.
References
-
- Munir A. Myxedema coma. J Ayub Med Coll Abbottabad. 2018 Jan-Mar;30(1):119–120. - PubMed
-
- Santiago R, Rashkin MC. Lithium toxicity and myxedema coma in an elderly woman. J Emerg Med. 1990;8(1):63–66. - PubMed
-
- Hawatmeh A, Thawabi M, Abuarqoub A, Shamoon F. Amiodarone induced myxedema coma: Two case reports and literature review. Heart Lung. 2018 Jul Aug;47(4):429–431. - PubMed
-
- Milkau M, Sayk F. Thyroid Storm and Myxedema Coma. Dtsch Med Wochenschr. 2018 Mar;143(6):397–405. - PubMed
-
- Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med. 1997;126(1):63–73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical